News & Press Releases

  • 18 April 2017 - PRESS RELEASE

    DZIF Prize for Translational Infection Research


    The DZIF Academy is pleased to open the call for application for the fourth DZIF Prize for Translational Infection Research. The German Center for Infection Research (DZIF) will award a prize of 5.000 Euro for exceptional translational infection research. The call is open to all infection researchers in Germany. Application Deadline: June 20, 2017.more ]

  • 13 April 2017 - PRESS RELEASE

    How an Ebola vaccine candidate activates our immune system

    EBOV 115

    In 2016, a clinical phase I trial on a potential vaccine against the dreaded Ebola virus was successfully completed. The tested vaccine “rVSV-ZEBOV” proved to be safe and effective. In a further trial, DZIF scientists from the University Medical Center Hamburg-Eppendorf (UKE) have now shown in detail how our immune systems react to the vaccine for the first time. This is an important step on the path to licensing a vaccine. more ]

  • 29 March 2017 - PRESS RELEASE

    New malaria prophylaxis promising in clinical trial


    Researchers from the University of Tübingen and the DZIF show medicine is effective when the timing is right. Their new active substance – DSM 265 – demonstrated a good prophylactic effect for Malaria. 21 healthy volunteers participated in the trial. The results have been published in the medical journal The Lancet Infectious Diseases.more ]

  • 09 March 2017 - PRESS RELEASE

    Memento Award 2017 goes to tropical disease specialists from Tübingen


    This year, the Memento Research Award for neglected diseases goes to Dr Carsten Köhler and Prof Peter Kremsner from the Institute of Tropical Diseases at the University Hospital Tübingen. With this, the jury honours their contributions to improving malaria treatment. more ]

  • 09 March 2017 - PRESS RELEASE

    Dampened immunity during pregnancy promotes evolution of more virulent flu


    During pregnancy, a mother’s immune system is suppressed to protect the fetus, which is perceived as a foreign body because it is genetically different. A partly DZIF funded study in mice found that suppressed immunity during pregnancy creates a window of opportunity for the H1N1 influenza virus to infect the mother and to rapidly, within a few days, mutate into a more virulent strain. The findings appear in Cell Host & Microbe on March 8.more ]

  • 27 February 2017 - INTERVIEW

    A list of pathogens sets priorities for antibiotic research


    The spread of antibiotic resistant bacteria is causing concern—and the call for new agents is getting louder and louder. But which antibiotics are needed most urgently? Today, for the first time, the World Health Organisation (WHO) has published a list of 12 bacteria groups which are to be given priority for future new antibiotic research and development. more ]

  • 23 February 2017 - PRESS RELEASE

    HIV infection: the strategy of resting cells


    The human immunodeficiency virus has to overcome major obstacles to infect inactive immune cells. DZIF scientists have investigated the defence mechanism of these cells and found indications of a new anti-viral mechanism. This knowledge could help develop more effective therapies against HIV.more ]

  • 20 February 2017 - PRESS RELEASE

    Stem cell research permits insight into early brain development disorders in Zika virus infections


    In a joint research project, Cologne scientists have now discovered a new mechanism with which the Zika virus contributes to the development of malformations in the newborns of Zika-infected mothers.  more ]

  • 17 February 2017 - INTERVIEW

    Targeting antibiotic-resistant bacteria specifically and promptly


    The spread of antibiotic-resistant bacteria is cause for concern–and no longer constitutes a problem that only hospitals face. In the current issue of Science, DZIF scientists from the University of Tübingen call for developing active agents that selectively fight these resistant bacteria before they cause infections. We spoke to one of the authors, Prof Andreas Peschel, about this strategy.more ]

  • 16 February 2017 - PRESS RELEASE

    New malaria vaccine effective in clinical trial


    DZIF researchers from the University of Tübingen in collaboration with the biotech company Sanaria Inc. have demonstrated in a clinical trial that a new vaccine for malaria called Sanaria® PfSPZ-CVac has been up to 100 percent effective when assessed at 10 weeks after last dose of vaccine. more ]

Results 1 to 10 of total 146